News

Stay up to date on our latest stories.

Filters

Hikma update on ANDA for generic Advair Diskus

Press Release, Inside Information
Hikma update on ANDA for generic Advair Diskus

Hikma Collaborates with the Department of Leukemia at the MD Anderson Cancer Center

Press Release, Corporate
Hikma Collaborates with the Department of Leukemia at the MD Anderson Cancer Center

Hikma delivers a solid financial performance in 2016 and makes significant strategic progress Strong growth in revenue a...

Press Release, Corporate
Hikma delivers a solid financial performance in 2016 and makes significant strategic progress Strong growth in revenue a...

Hikma Pharmaceuticals PLC (Hikma) will announce its preliminary financial results for the year ended 31 December 2016 on...

Press Release, Corporate
Hikma Pharmaceuticals PLC (Hikma) will announce its preliminary financial results for the year ended 31 December 2016 on...

Hikma Pharmaceuticals Health Partner of the World Economic Forum in Davos

Press Release, Responsibility
Hikma Pharmaceuticals Health Partner of the World Economic Forum in Davos

Trading Update (November 2016)

Press Release, Corporate
Trading Update (November 2016)

Hikma Pharmaceuticals Launches October Breast Cancer Awareness Campaign

Press Release, Responsibility
Hikma Pharmaceuticals Launches October Breast Cancer Awareness Campaign

Hikma Ventures invests in Propeller Health for the enhancement of leading respiratory technology platform

Press Release, Corporate
Hikma Ventures invests in Propeller Health for the enhancement of leading respiratory technology platform

Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”

Press Release, Corporate
Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”

Meet the Management Day

Press Release, Corporate
Meet the Management Day

Board Appointment and Succession

Press Release, Corporate
Board Appointment and Succession

Hikma Ventures invests in Chrono Therapeutics for the development of next generation trans-dermal drug delivery technolo...

Press Release, Corporate
Hikma Ventures invests in Chrono Therapeutics for the development of next generation trans-dermal drug delivery technolo...

Hikma delivers solid first half performance and reiterates full year revenue guidance of $2.0 billion to $2.1 billion

Press Release, Corporate
Hikma delivers solid first half performance and reiterates full year revenue guidance of $2.0 billion to $2.1 billion

Notice of Results (August 2016)

Press Release, Corporate
Notice of Results (August 2016)

Trading update

Press Release, Corporate
Trading update